Screener
Arcus Biosciences RCUS Pre-Tax Income
Pre-Tax Income at other companies
Other financials
Where this comes from
Reported directly by Arcus Biosciences in its filing.
Tagged under the XBRL concept us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest.
The source filing: Arcus Biosciences’s 10-Q, filed August 5, 2026.
- Filed
- Aug 5, 2026, 4:11 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001724521-26-000044
| Line item | Three Months Ended June 30, 2026 | Three Months Ended June 30, 2025 | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|---|---|
| Interest and other income, net | 8 | 10 | 17 | 21 |
| Interest expense | (3) | (2) | (6) | (3) |
| Total non-operating income, net | 5 | 8 | 11 | 18 |
| Income (loss) before income taxes | (91) | — | (219) | (112) |
| Income tax expense | — | — | — | — |
| Net income (loss) | $(91) | — | $(219) | $(112) |
| Net income (loss) per share: | ||||
| Basic | $(0.72) | — | $(1.74) | $(1.09) |
Item 1. Financial Statements
FAQ
- What is Arcus Biosciences's pre-tax income?
- Arcus Biosciences (RCUS) reported pre-tax income of -$91M in Q2 2026.
- What is the long-term trend for Arcus Biosciences's pre-tax income?
- Over 4 years (2021 to 2025), Arcus Biosciences's pre-tax income has grown at a 59.2% compound annual growth rate (CAGR), from $55M to -$353M.
- What does pre-tax income mean?
- Total income from all sources — operating income plus non-operating items like interest income, investment gains, and other income — before the provision for income taxes.
Ask your AI about Arcus Biosciences's pre-tax income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude